Goldman Sachs’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $130K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $5K | Sell |
|
|||||
|
2024
Q3 | $75.4K | Sell |
|
|||||
|
2024
Q2 | $208K | Buy |
|
|||||
|
2024
Q1 | $121K | Sell |
|
|||||
|
2023
Q4 | $317K | Buy |
|
|||||
|
2023
Q3 | $660K | Sell |
|
|||||
|
2023
Q2 | $1.1M | Buy |
|
|||||
|
2023
Q1 | $636K | Sell |
|
|||||
|
2022
Q4 | $1.11M | Buy |
|
|||||
|
2022
Q3 | $1.37M | Sell |
|
|||||
|
2022
Q2 | $892K | Buy |
|
|||||
|
2022
Q1 | $730K | Buy |
|
|||||
|
2021
Q4 | $1.2M | Sell |
|
|||||
|
2021
Q3 | $2.6M | Buy |
|
|||||
|
2021
Q2 | $1.56M | Sell |
|
|||||
|
2021
Q1 | $6.56M | Buy |
|
|||||
|
2020
Q4 | $1.16M | Sell |
|
|||||
|
2020
Q3 | $1.72M | Buy |
|